Matching slides 303,780
Current window 44,641-44,670
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

44,641-44,670 of 303,780

filter-aware
07
The slide uses a timeline-like bar to indicate the current development stage (IND-enabling) for two specific molecules.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 2 hits
08
The slide uses a structured table to present key drug development metrics.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 2 hits
09
AbCellera | Investor Conference Presentation Deck | 14 slidesAbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 2 hits
11
The slide demonstrates a therapeutic window improvement by comparing efficacy (killing) vs safety (cytokine release) across concentration gradients.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 2 hits
13
AbCellera | Investor Conference Presentation Deck | 14 slidesAbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 2 hits
03
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction2 hits
05
The slide uses a circular diagram to represent the AI-driven feedback loop between wet-lab data generation and model training.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
06
The slide illustrates a process flow from target antigen to AI-designed antibodies.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
07
The slide uses a circular process diagram to link AI design with wet-lab validation.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
08
The slide uses a linear process flow with icons representing the transformation of biological inputs through AI models.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
09
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
10
The right side uses a dot-plot style visualization to represent the economic structure of a partnership, moving from R&D funding to commercial royalties.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet2 hits
12
The slide uses a Gantt-style chart to show the progress of three assets (ABS-101, ABS-201, ABS-301) across development stages.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet2 hits
13
The slide uses a split-screen approach: biological mechanism on the left, market sizing on the right.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet2 hits
14
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
15
Uses a before-after framing to show how affinity translates to potency.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
16
The slide uses a before-after structure to demonstrate the superiority of the ABS-101 platform over competitors (RVT-3101, MK-7240).Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
17
The visual shows a 3D protein structure with highlighted binding regions for various antibodies.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
18
The table uses checkmarks and crosses to indicate the presence or absence of specific therapeutic attributes across four different drug programs.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
19
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
20
Includes logos of partner/talent source institutions and photos of the team and lab facilities.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
21
Includes a dog (Penelope) as 'Chief Morale Officer' as a lighthearted team member entry.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations 2 hits
07
The chart uses a stacked bar format to show both total revenue growth and the changing composition of product contributions over time.Alkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Evidence2 hits
23
The slide outlines a standard clinical trial protocol structure.Alkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
27
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Resolution2 hits
19
The slide details a specific licensing deal with Qilu Pharmaceutical, including financial terms and geographic scope.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution2 hits
03
The infinity loop suggests a continuous, self-reinforcing process of innovation.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Humble Origins2 hits
09
The slide uses a 2x2 grid layout to present key performance indicators.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Rising SuccessLoop · Why Now2 hits
18
Kaplan-Meier survival curve showing probability of being retreated with IVIg.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet2 hits
23
The diagram is a variation of a flywheel or infinity loop representing the integration of clinical development and disease insight.argenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Ultimate Achievement2 hits